Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 19Esophageal Squamous Cell Carcinoma 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Ovarian Neoplasms 2Neoplasm, Residual 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Waldenstrom Macroglobulinemia 1Turcot syndrome 1Testicular Neoplasms 1Surgery 1Stress, Psychological 1Squamous Cell Carcinoma of External Auditory Canal 1Solitary Fibrous Tumor, Pleural 1Seminoma 1Recurrence 1Postoperative Complications 1

Interventions

Trastuzumab 14pertuzumab 10Docetaxel 7tucatinib 4pyrotinib 4Paclitaxel 4Capecitabine 4Carboplatin 2Ado-Trastuzumab Emtansine 2trastuzumab deruxtecan 1pegfilgrastim 1neratinib 1exemestane 1dalpiciclib 1atezolizumab 1Neoadjuvant Therapy 1Leuprolide 1Isovaleryl-CoA Dehydrogenase 1Injections 1Goserelin 1Genetic Testing 1Fulvestrant 1Fluorodeoxyglucose F18 1Blood Specimen Collection 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HER2-positive Breast Cancer × Neoadjuvant Therapy × 1 year × Clear all
NCT07616440 2026-06-04

Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Recruiting
20 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡